SCHEMBL2431819

SCHEMBL2431819

CCC(c1cccc(N(C(C)C)C(C)C)c1)c1cc(C=O)ccc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
LMNA P02545 4/20 0.37
MAPT P10636 3/20 0.37
CHRM2 P08172 2/20 0.37
CHRM5 P08912 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
HRH1 P35367 2/20 0.37
ESR1 P03372 1/20 0.37
CHRM4 P08173 1/20 0.37
KCNE1 P15382 1/20 0.37
PTGS1 P23219 1/20 0.37
HRH2 P25021 1/20 0.37
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
ADRA1A P35348 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4412379 0.83 CHRM1 (0.54) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL3721172 0.83 CHRM1 (0.54) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL6473873 0.82 HSP90AA1 (0.41) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL11296361 0.82 TBXAS1 (0.34) ALDH1A1MAPTNPSR1HTTTRIM24
SCHEMBL2167352 0.81 CHRM3 (0.38) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL7752284 0.81 CHRM3 (0.38) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL722593 0.81 CHRM3 (0.38) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL19212491 0.79 ALDH1A1 (0.35) ALDH1A1LMNAKDM4EGAASMN1; SMN2
SCHEMBL4189998 0.79 MAPT (0.38) ALDH1A1HDAC4HDAC2HDAC8LMNA
SCHEMBL10106396 0.78 ALDH1A1 (0.39) ALDH1A1HDAC4HDAC2HDAC8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364966-A1 Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine LEK Pharmaceuticals d.d. (SI) 2011-09-14 EP disclosed